Clinical Trial: Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)

U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07625488) titled 'Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)' on May 20.

Brief Summary: Regular endurance exercise is widely known to improve cardiovascular health and reduce the risk of heart disease. Yet several imaging studies have shown that male endurance athletes have a higher prevalence of coronary artery calcification (CAC) and calcified plaque than less active individuals. It remains unclear whether this represents harmful progression of coronary artery disease or a more benign, stable form of atherosclerosis. Understanding this distinction is essential, because coronary atherosclerosis is the leading cause of exercise-relat...